Company intelligence / Profile preview

Cellution Biologics

Atlanta, Georgia, United Statescellutionbiologics.com ↗

Ownership: Private
Development stage: Other

Overview

Cellution Biologics offers advanced human placental tissue-derived products, including dehydrated amniotic membrane matrices processed with proprietary technology. Their lead product(s) have received FDA Tissue Reference Group recognition and meet/exceed AATB, AABB, CAP, and ISO 13485 standards. The company is establishing distribution in the US to support commercial launch.

Therapeutic areas: DermatologyOther
Modalities: Human tissue-based therapyPlacental tissue-derived productsAmniotic membrane-based wound care dressings
Industry: Consumable Medical Devices

Partnerships

No major pharmaceutical partnerships disclosed; strategic relationship with parent LifeCell International provides access to one of the world’s largest placental tissue banks.

Beyond the preview

Go deeper on Cellution Biologics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellution Biologics.

Explore the full profile